Celgene Competitors and Similar CompaniesClear all

Celgene's competitors and similar companies include Sanofi, Amgen, Gilead Sciences, Regeneron Pharmaceuticals, BioNTech and Idorsia.
Celgene
Celgene
Celgene is a biopharmaceutical company developing therapies for the treatment of cancer and inflammatory diseases.
Sanofi
Sanofi
Sanofi is a global healthcare company engaged in the research, development, manufacture, and marketing of therapeutic solutions.
Amgen
Amgen
Amgen (formerly known as Applied Molecular Genetics) is a biotech company discovering, developing, manufacturing, and delivering human therapeutics.
Gilead Sciences
Gilead Sciences
Gilead Sciences is a research-based biopharmaceutical company focused on the discovery, development, and commercialization of medicines.
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals is a biopharmaceutical company that develops, manufactures, and markets medicines.
BioNTech
BioNTech
BioNTech is biopharmaceutical company pioneering the development of individualized therapies for cancer and other diseases.
Idorsia
Idorsia
Idorsia, a biopharmaceutical company, discovers, develops, and commercializes drugs for unmet medical needs.
Founding Date
Founding Date
1986
Founding Date
2004
Founding Date
1980
Founding Date
1987
Founding Date
1988
Founding Date
2008
Founding Date
2017
Type
Type
Subsidiary
Type
Public
Type
Public
Type
Public
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
HQ
Locations
Paris, FR HQ
Hydra, DZ
Macquarie Park, AU
Wien, AT
Dhaka, BD
Brussel, BE
Geel, BE
see more
Locations
Thousand Oaks, US HQ
Hydra, DZ
Vicente López, AR
Sydney, AU
Wien, AT
Diegem, BE
Santo Amaro, BR
see more
Locations
Foster City, US HQ
Buenos Aires, AR
Melbourne, AU
Wien, AT
Machelen, BE
São Paulo, BR
Edmonton, CA
see more
Locations
Tarrytown, US HQ
Mississauga, CA
München, DE
Bengaluru, IN
Dublin, IE
Limerick, IE
Tokyo, JP
see more
Locations
Mainz, DE HQ
Halle (Saale), DE
Idar Oberstein, DE
Marburg, DE
Neuried, DE
Planegg, DE
Cambridge, US
see more
Locations
HQ
Employees
Employees
8,85219% increase
Employees
95,4424% decrease
Employees
25,200
Employees
14,4006% increase
Employees
12,2563% increase
Employees
5,100
Employees
8007% increase
Valuation ($)
Valuation ($)
N/A
Valuation ($)
N/A
Valuation ($)
140.3 b
Valuation ($)
94.3 b
Valuation ($)
89.4 b
Valuation ($)
25.7 b
Valuation ($)
N/A
Twitter followers
Twitter followers
26.8 k
Twitter followers
151.6 k
Twitter followers
123.5 k
Twitter followers
73.8 k
Twitter followers
32.5 k
Twitter followers
83.5 k
Twitter followers
2.1 k
Number of tweets (last 30 days)
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
35
Number of tweets (last 30 days)
91
Number of tweets (last 30 days)
22
Number of tweets (last 30 days)
4
Number of tweets (last 30 days)
2
Number of tweets (last 30 days)
12
Average likes per tweet (last 30 days)
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
15.6
Average likes per tweet (last 30 days)
4.8
Average likes per tweet (last 30 days)
48.1
Average likes per tweet (last 30 days)
4.8
Average likes per tweet (last 30 days)
87
Average likes per tweet (last 30 days)
3.3
Percentage of tweets with engagement (last 30 days)
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
91.43%
Percentage of tweets with engagement (last 30 days)
97.8%
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
100%
Employee Rating
Employee Rating
4
Employee Rating
3.9
Employee Rating
4.1
Employee Rating
3.8
Employee Rating
4
Employee Rating
3.3
Employee Rating
3.7

Financial

Revenue (est.)
Revenue (est.)
$15.3b (FY, 2018)
Revenue (est.)
€43b (FY, 2022)
Revenue (est.)
$26.3b (FY, 2022)
Revenue (est.)
$27.3b (FY, 2022)
Revenue (est.)
$12.2b (FY, 2022)
Revenue (est.)
€17.3b (FY, 2022)
Revenue (est.)
CHF97.1m (FY, 2022)
Cost of goods
Cost of goods
$587m (FY, 2018)
Cost of goods
€11.9b (FY, 2022)
Cost of goods
$6.4b (FY, 2022)
Cost of goods
$5.7b (FY, 2022)
Cost of goods
N/A
Cost of goods
€2.9b (FY, 2022)
Cost of goods
CHF6.3m (FY, 2022)
Gross profit
Gross profit
$14.7b (FY, 2018)
Gross profit
€34.8b (FY, 2022)
Gross profit
$19.9b (FY, 2022)
Gross profit
$21.6b (FY, 2022)
Gross profit
N/A
Gross profit
€14.5b (FY, 2022)
Gross profit
CHF90.8m (FY, 2022)
Net income
Net income
$4b (FY, 2018)
Net income
€8.4b (FY, 2022)
Net income
$6.6b (FY, 2022)
Net income
$4.6b (FY, 2022)
Net income
$4.3b (FY, 2022)
Net income
€9.4b (FY, 2022)
Net income
(CHF827.9m) (FY, 2022)

Operating

Countries
Countries
N/A
Countries
N/A
Countries
100 (FY, 2020)
Countries
35 (FY, 2021)
Countries
N/A
Countries
N/A
Countries
N/A
Patents (EU)
Patents (EU)
N/A
Patents (EU)
N/A
Patents (EU)
21 (FY, 2020)
Patents (EU)
N/A
Patents (EU)
17 (FY, 2020)
Patents (EU)
N/A
Patents (EU)
N/A
Patents (US)
Patents (US)
N/A
Patents (US)
N/A
Patents (US)
31 (FY, 2020)
Patents (US)
N/A
Patents (US)
31 (FY, 2020)
Patents (US)
45 (Oct, 2019)
Patents (US)
N/A
Phase I Trials Products
Phase I Trials Products
N/A
Phase I Trials Products
N/A
Phase I Trials Products
20 (FY, 2020)
Phase I Trials Products
N/A
Phase I Trials Products
N/A
Phase I Trials Products
8 (Oct, 2019)
Phase I Trials Products
N/A
Phase I Trials Products (Oncology)
Phase I Trials Products (Oncology)
N/A
Phase I Trials Products (Oncology)
9 (FY, 2021)
Phase I Trials Products (Oncology)
N/A
Phase I Trials Products (Oncology)
7 (FY, 2019)
Phase I Trials Products (Oncology)
N/A
Phase I Trials Products (Oncology)
N/A
Phase I Trials Products (Oncology)
N/A
Phase II Trials Products
Phase II Trials Products
N/A
Phase II Trials Products
N/A
Phase II Trials Products
5 (FY, 2020)
Phase II Trials Products
N/A
Phase II Trials Products
N/A
Phase II Trials Products
1 (Oct, 2019)
Phase II Trials Products
N/A
Phase II Trials Products (Oncology)
Phase II Trials Products (Oncology)
N/A
Phase II Trials Products (Oncology)
12 (FY, 2021)
Phase II Trials Products (Oncology)
N/A
Phase II Trials Products (Oncology)
1 (FY, 2021)
Phase II Trials Products (Oncology)
N/A
Phase II Trials Products (Oncology)
N/A
Phase II Trials Products (Oncology)
N/A
Phase III Trials Products
Phase III Trials Products
N/A
Phase III Trials Products
N/A
Phase III Trials Products
11 (FY, 2020)
Phase III Trials Products
9 (FY, 2021)
Phase III Trials Products
N/A
Phase III Trials Products
N/A
Phase III Trials Products
N/A
Products
Products
N/A
Products
N/A
Products
N/A
Products
21 (FY, 2021)
Products
7 (FY, 2020)
Products
N/A
Products
N/A
Projects in R&D Pipeline
Projects in R&D Pipeline
N/A
Projects in R&D Pipeline
91 (FY, 2019)
Projects in R&D Pipeline
N/A
Projects in R&D Pipeline
N/A
Projects in R&D Pipeline
N/A
Projects in R&D Pipeline
N/A
Projects in R&D Pipeline
12 (FY, 2019)

Funding

Total funding raised
Total funding raised
N/A
Total funding raised
$ 310m
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
$ 53.9m
Total funding raised
$ 1.4b
Total funding raised
N/A
For sources of this data, please see the company profile

View Company Profiles

Sanofi
HQ
Paris, FR
Employees
95,442↓ 4% decrease

Sanofi is a global healthcare company engaged in the research, development, manufacture, and marketing of therapeutic solutions.

View company
Amgen
HQ
Thousand Oaks, US
Employees
25,200

Amgen (formerly known as Applied Molecular Genetics) is a biotech company discovering, developing, manufacturing, and delivering human therapeutics.

View company
Gilead Sciences
HQ
Foster City, US
Employees
14,400↑ 6% increase

Gilead Sciences is a research-based biopharmaceutical company focused on the discovery, development, and commercialization of medicines.

View company
Regeneron Pharmaceuticals
HQ
Tarrytown, US
Employees
12,256↑ 3% increase

Regeneron Pharmaceuticals is a biopharmaceutical company that develops, manufactures, and markets medicines.

View company